KaNDy Therapeutics Investors
KaNDy Therapeutics is a clinical-stage company focused on optimising the potential of NT-814.
Employee Number:
1-10
Industry:
Longevity Finance
Number Of Exists:
Series C
Investor Type:
Healthcare Company
Founded Date:
2017